Skip to main content
Premium Trial:

Request an Annual Quote

Illumina to Handle Genotyping for Two Large Cancer Research UK Projects

NEW YORK (GenomeWeb News) — Illumina will use its Infinium and Beadchip tools to genotype more than 15,000 samples for lung and ovarian cancer research studies organized by Cancer Research UK, the company said today.
 
For the program to discover genetic risk factors to lung cancer, Illumina will run more than 2,000 samples on the HumanHap550 Beadchip and 5,600 samples on an iSelect Custom Beadchip for the University of Cambridge.
 
In the ovarian cancer study, conducted for the University of Cambridge and the University of London, Illumina will process more than 2,000 samples on the HumanHap550 and 6,000 samples on the iSelect, the company said.
 
Illumina said the programs are the third and fourth for which it has been asked to contribute for Cancer Research UK.
 
Financial terms of the studies, both of which will be funded by Cancer Research UK, were not released.  

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.